Severe PAD: ABI <0.40
An ankle-brachial index (ABI) below 0.40 is considered severe peripheral artery disease (PAD). While the American Heart Association guidelines establish <0.90 as the diagnostic threshold for PAD, they specifically note that an ABI ≤0.80 represents more significant disease, and values <0.40 indicate severe obstruction 1.
ABI Classification Framework
The evidence supports a tiered approach to ABI interpretation:
- Normal: 0.91-1.40
- Borderline: 0.91-1.00 (warrants further evaluation) 1
- PAD (diagnostic threshold): <0.90 1
- Moderate PAD: 0.40-0.79
- Severe PAD: <0.40
Clinical Context
In the PORTRAIT study of 1,251 patients with intermittent claudication, researchers categorized disease severity as mild (ABI >0.80), moderate (0.40-0.79), and severe (<0.40), with only 8.1% falling into the severe category 2. This classification aligns with clinical practice where ABI <0.40 typically indicates critical limb ischemia risk and often necessitates urgent vascular intervention.
Mortality Risk Stratification
The severity classification has direct mortality implications. Research demonstrates a linear relationship between lower ABI values and death risk 3:
- ABI 0.7-0.89: Hazard ratio 1.7 for mortality
- ABI <0.5: Hazard ratio 3.6 for mortality
This gradient reinforces that values below 0.40-0.50 represent a distinct high-risk category requiring aggressive management.
Critical Caveats
Important limitation: The ABI can be falsely elevated (>1.40) in patients with calcified, non-compressible vessels (common in diabetes and chronic kidney disease), masking severe disease 1. In these cases, toe-brachial index or imaging studies are mandatory 1.
Measurement precision matters: Given the 95% confidence interval of ±0.10 for ABI measurements, values near threshold categories (e.g., 0.42-0.48) may require repeat testing or additional vascular studies to confirm severity 1.
The guideline consensus clearly positions ABI <0.40 as the severe PAD threshold, distinguishing patients who require urgent vascular evaluation and intervention from those with moderate disease who may be managed more conservatively 1.